Abstract
IL-23- and IL-17A-producing CD4+ T cell (Th17 cell) axis plays a crucial role in the development of chronic inflammatory diseases. In addition, it has been demonstrated that Th17 cells and their cytokines such as IL-17A and IL-17F are involved in the pathogenesis of severe asthma. Recently, IL-22, an IL-10 family cytokine that is produced by Th17 cells, has been shown to be expressed at the site of allergic airway inflammation and to inhibit allergic inflammation in mice. In addition to Th17 cells, innate lymphoid cells also produce IL-22 in response to allergen challenge. Functional IL-22 receptor complex is expressed on lung epithelial cells, and IL-22 inhibits cytokine and chemokine production from lung epithelial cells. In this paper, we summarize the recent progress on the roles of IL-22 in the regulation of allergic airway inflammation and discuss its therapeutic potential in asthma.
Highlights
Asthma is a chronic inflammatory disease that is accompanied by intense eosinophilic infiltration, goblet cell hyperplasia, and airway hyperreactivity (AHR) [1]
Several lines of evidence have shown that Th2 cell-derived cytokines and Th17 cell-derived cytokines such as IL-17A and IL-17F are expressed in the airways in severe asthma patients, and that the levels of IL-17A and IL-17F in the airways are correlated with the severity of asthma, suggesting the involvement of Th17 cell-derived cytokines in the pathogenesis of severe asthma [4, 5]
We have shown that the majority of IL-22-producing cells at the site of allergic airway inflammation are CD4+ T cells and that one third of the IL-22-producing CD4+ T cells produce IL-17A [22], suggesting that some of IL-22-producing CD4+ T cells in a murine asthma model are Th17 cells
Summary
Asthma is a chronic inflammatory disease that is accompanied by intense eosinophilic infiltration, goblet cell hyperplasia, and airway hyperreactivity (AHR) [1]. It is well established that these features are mediated by antigen-specific Th2 cells and their cytokines including IL4, IL-5, and IL-13 [2, 3]. We and others have shown that Th17 cells are involved in the development of antigen-induced airway inflammation in murine asthma models [6,7,8]. Recent studies have shown that IL-22, one of Th17 cell-derived cytokines, is detected in bronchoalveolar lavage fluid (BALF) in murine asthma models [8, 9]. We briefly summarize the roles of IL-22 in the regulation of allergic inflammation in asthma
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
